论文部分内容阅读
BACKGROUND:β-secretase(β-site APP cleavage rate-limiting enzyme,BACE) has been proposed as a promising therapeutic target for Alzheimer's disease(AD).BACE inhibition reduces production of β-amyloid peptide(Aβ) and promotes neural regeneration.Two cata